Caldaret
- Generic Name
- Caldaret
- Drug Type
- Small Molecule
- Chemical Formula
- C11H16N2O3S
- CAS Number
- 133804-44-1
- Unique Ingredient Identifier
- 9L3Y3IJ2HI
- Indication
Investigated for use/treatment in heart disease and myocardial infarction.
MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients
Phase 2
Completed
- Conditions
- Myocardial Infarction
- First Posted Date
- 2004-02-18
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 414
- Registration Number
- NCT00078013
- Locations
- 🇺🇸
Massachusetts General Hospital/ Harvard Medical School, Boston, Massachusetts, United States
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
- First Posted Date
- 2002-11-21
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 204
- Registration Number
- NCT00050076
- Locations
- 🇺🇸
LAC & USC Medical Center, Los Angeles, California, United States
🇺🇸Apex Research Institute, Santa Ana, California, United States
🇺🇸Medical Group of Fort Wayne, PC, Fort Wayne, Indiana, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath